Status:
COMPLETED
Evaluation of Clinical Effectiveness and Safety of Locaste 8F Guiding Catheter in Neurovascular Interventional Surgery
Lead Sponsor:
Keuro MedTech
Conditions:
Stroke
Hemorrhagic Strokes
Eligibility:
All Genders
18+ years
Brief Summary
The Locaste 8F Delivery Catheter by Kai MedTech has been launched in China since 2022 and has been widely used clinically. It won the government tendering in many provinces in China in early 2024. As ...
Detailed Description
This clinical investigation is a single-arm, retrospective, multicenter clinical study of a medical device marketed in China. Patients with Locaste 8F Guiding Catheter used in the neurovascular interv...
Eligibility Criteria
Inclusion
- Age of 18 years or older;
- Undertaken a neurovascular surgery procedure including Locaste 8F Guiding Catheter;
- Available images of Locaste 8F Guiding Catheter in the neurovascular surgery;
Exclusion
- Disorders of vascular fragility (e.g. Ehlers-Danlos syndrome)
- Prior vascular dissection or injury to vessels to be catheterized
Key Trial Info
Start Date :
May 21 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 7 2024
Estimated Enrollment :
113 Patients enrolled
Trial Details
Trial ID
NCT06917248
Start Date
May 21 2024
End Date
October 7 2024
Last Update
June 24 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Xinxiang City Central Hospital
Xinxiang, Henan, China, 453000
2
Zhumadian City Central Hospital
Zhumadian, Henan, China, 463000